European Commission secures EU access to Remdesivir for treatment of COVID-19

coronavirus 2021

(Credit: Unsplash)

This article is brought to you in association with the European Commission.

Yesterday, the European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir. Veklury was the first medicine authorised at EU level for treatment of COVID-19. As from early August onwards, and in order to meet immediate needs, batches of Veklury will be made available to Member States and the UK, with the coordination and support of the Commission.

Stella Kyriakides, Commissioner for Health and Food Safety, said: “In recent weeks, the Commission has been working tirelessly with Gilead to reach an agreement to ensure that stocks of the first treatment authorised against COVID-19 are delivered to the EU. A contract has been signed yesterday, less than a month after the authorisation of Remdesivir, which will allow the delivery of treatments from early August for thousands of patients. The Commission is leaving no stone unturned in its efforts to secure access to safe and efficient treatments, and is supporting the development of vaccines against coronavirus. Yesterday’s agreement is another important step forward in our fight to overcome this disease”.

The Commission’s Emergency Support Instrument will finance the contract, worth a total of €63 million. This will ensure the treatment of approximately 30,000 patients presenting severe COVID-19 symptoms. This will help to cover the current needs over the next few months, while ensuring a fair distribution at EU level, based on an allocation key, taking into account the advice from the European Centre for Disease Prevention and Control.

The Commission is now also preparing a joint procurement for further supplies of the medicine, expected to cover additional needs and supplies as from October onwards.


On 3 July, Remdesivir became the first treatment to be authorised for a conditional marketing authorisation. This authorisation facilitates early access to medicines in public health emergency situations, such as the current pandemic.

Remdesivir is a treatment against COVID-19 for adults and adolescents as from age 12 with pneumonia who require supplemental oxygen. The application for the marketing authorisation was submitted to the European Medicines Agency (EMA) on 8 June. EMA’s recommendation was endorsed by the Member States through the Standing Committee on Medicinal Products for Human Use.

While authorised in the EU, the medicine continues to be monitored to ensure safety. Gilead has also been requested to submit the final reports of the Remdesivir studies to the EMA by December 2020 as part of the conditions to be fulfilled to move from a conditional marketing authorisation to a full marketing authorisation. Further data on the effectiveness and safety of the medicine is expected to be submitted by August 2020 in order to finalise this process.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Ukrainian civil war: Is this the beginning of the end or the end of the beginning?

Wolfgang Schäuble: “Without European unification, there would be no German unity”

Inequality triggered protests across Latin America. Here’s how the youth can help

European Commission and World Bank Group renew agreement to strengthen development cooperation

Public Health equality in a trench

Vulnerable young people must not be blamed & stigmatised for violent radicalisation

Hunger and obesity in Latin America and the Caribbean compounded by inequality: UN report

What wealth managers can learn from family dynamics

This research can help organizations plan for different COVID-19 scenarios

Trump ‘used’ G20 to side with Putin and split climate and trade packs

Bid to raise $5.5 billion for millions of Syrians and their host communities

EU budget 2020: Commission focuses its proposal on jobs, growth and security

Fostering defence innovation through the European Defence Fund

Young students envision turning Europe into an Entrepreneurial Society

State aid: Commission opens investigation into proposed public support for Peugeot plant in Spain

Facts, not fear, will stop COVID-19 – so how should we talk about it?

Germany may prove right rejecting Commission’s bank resolution scheme

Merkel refuses to consider the North-South schism of Eurozone

EU budget: the Common Agricultural Policy beyond 2020


The impact of mobile and rapid digital adoption on how India consumes

Chinese Premier Li Keqiang’s speech from World Economic Forum’s Annual Meeting of New Champions

Remarks by H.E. Ambassador Zhang Ming At the Reception in Celebration of the 70th Anniversary of the Founding of the People’s Republic of China

Attempt to defy international law over Golan Heights sovereignty ‘doomed to failure’ Security Council hears

Banking on sustainability – what’s next?

China’s stock markets show recovery signs while EU is closely watching in anticipation of the €10bn investment

OECD’s Gurría calls for overhaul of economic thinking to address global challenges

Commission reports on 2019 European elections: fostering European debates and securing free and fair elections

10 lessons from the COVID-19 frontline for a more gender-equal world

6 charts that show how Japan’s economy stacks up as it enters a new era

The EU Commission does nothing about the food retailing oligopoly

Airships, solar planes and Soviet-era sea skimmers … here’s how we fix air travel

UN chief welcomes possibility of resumed talks between US and North Korea

The two big uncertainties shaping our future

Coronavirus could worsen hunger in the developing world

De-escalate now, to steer Yemen off ‘precarious path’, UN Security Council hears

Roxane in Cambodia

EU leaders agree on 2030 Climate and Energy Package: is “flexible” brave enough?

GSMA Mobile 360 – Africa on 16-18 July 2019, in association with The European Sting

Batteries included: how better storage can transform renewable energy

Forget 2009, this is the real credit crisis of our time

The European Sting live from the World Economic Forum 2015 in Davos

This is how India can become the next Silicon Valley

UN condemns attack on Ebola treatment centre in DR Congo which left doctor dead, two others injured

Armed insurgency in north-east Nigeria ‘has created a humanitarian tragedy’

It is me

Why a global recession isn’t inevitable

European Court of Justice to Google: It is #righttobeforgotten but not #righttoberemembered

The great sustainable reset: The new world of work after the pandemic

MWC 2016 LIVE: Qualcomm looks to pick up Hamilton’s winning ways

The Bavarians threaten Berlin and Brussels with immigration crisis

Chinese “BeiDou” GPS goes to market

Stop illegal trade in cats and dogs, says European Parliament

MEPs criticise “America first” policy

Militias force nearly 2,000 to leave Libyan capital’s largest shelter for internally-displaced: UNHCR

Amidst high trade tensions and policy uncertainty, UN cuts economic growth forecast

Four in 10 indigenous languages at risk of disappearing, warn UN human rights experts

A Sting Exclusive: “Europe must be more ambitious in COP21 and lead on climate finance and sustainable development”, Green UK MEP Jean Lambert points out from Brussels

Brussels to tear down the trade wall with Mexico as opposed to Trump’s “walls”

Public climate finance to developing countries is rising

More Stings?


Speak your Mind Here

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s